HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The alpha subunit of GTP-binding protein G0 in neuroblastoma: correlation with advanced disease stage.

Abstract
Tissue levels of the alpha subunit of G protein G0 (G0 alpha) were measured in solid tumors from pediatric patients by immunoassay. G0 alpha concentrations were determined in the supernatant obtained by centrifugation of tissue homogenates prepared in the presence (total G0 alpha) or absence of 2% sodium cholate (soluble G0 alpha). Mean G0 alpha concentrations (total G0 alpha and soluble G0 alpha) in neuroblastomas (7 ganglioneuromas, 13 ganglioneuroblastomas, and 50 neuroblastomas) were over 50-fold higher than those in other solid tumors from pediatric patients (n = 13). Mean total G0 alpha and soluble G0 alpha concentrations were 207.0 +/- 166.0 (SD) ng/mg of cholate-extractable protein and 58.6 +/- 47.0 ng/mg of soluble protein, respectively, in the neuroblastoma group (n = 70). Total G0 alpha concentration decreased with disease stage and was strongly correlated with outcome in patients with neuroblastoma. The mean total G0 alpha concentration in tumors from younger patients (< 1 year old) was 297.0 +/- 137.0 ng/mg of cholate-extractable protein, significantly higher than in tumors from older patients (140.0 +/- 155.0 ng/mg cholate-extractable protein, P < 0.0001). These results suggest that total G0 alpha levels in neuroblastoma may indicate the degree of malignancy.
AuthorsY Ishiguro, K Kato, T Asano, H Akatsuka, H Iwata, F Ito, T Ito
JournalCancer research (Cancer Res) Vol. 54 Issue 9 Pg. 2334-6 (May 01 1994) ISSN: 0008-5472 [Print] United States
PMID8162577 (Publication Type: Journal Article)
Chemical References
  • GTP-Binding Proteins
Topics
  • Age Factors
  • Child
  • Child, Preschool
  • GTP-Binding Proteins (analysis)
  • Humans
  • Infant
  • Neoplasm Staging
  • Neuroblastoma (chemistry, mortality, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: